SG
AMPE

Societe Generale’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Societe Generale’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$14K Buy
+36
New +$39.3K ﹤0.01% 2525

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Societe Generale's AMPE Position: Q2 2016 in Review

Societe Generale opened a new position in Ampio Pharmaceuticals Inc. (AMPE) in Q2 2016: 36 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #2525 among its holdings.

74 funds tracked by Wall St. Rank hold AMPE as of Q2 2016.

  • Societe Generale held 36 shares of Ampio Pharmaceuticals Inc. worth $14K as of Q2 2016.
  • Ampio Pharmaceuticals Inc. was a new Societe Generale position in Q2 2016.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #2525 holding.
  • 74 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.